Back to Search
Start Over
Long-term outcomes of frontline 90 Y-ibritumomab tiuxetan in marginal zone lymphoma.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (13), pp. 3234-3238. Date of Electronic Publication: 2020 Aug 05. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 61
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 32755329
- Full Text :
- https://doi.org/10.1080/10428194.2020.1802449